A Phase IV Trial With Pramipexole to Investigate the Effects on RLS Symptoms and Sleep Disturbance in Patients With RLS

NCT00349531 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

369

Enrollment

INDUSTRY

Sponsor class

Conditions

Restless Legs Syndrome

Interventions

DRUG: Pramipexole

Sponsor

Boehringer Ingelheim